deltatrials
Completed OBSERVATIONAL NCT00793390

Case-Control Study of Inflammatory Breast Cancer in North Africa

A Case-Control Study of Inflammatory Breast Cancer in North Africa

Sponsor: National Cancer Institute (NCI)

Conditions Diabetes
Updated 21 times since 2017 Last updated: Dec 23, 2020 Started: Nov 17, 2008 Primary completion: Sep 30, 2018 Completion: Sep 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 21 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Oct 2019 · 9 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshot~Mar 2020 – ~May 2020 · 2 months · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

21 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Dec 2021 — Jul 2024 [monthly]

    Completed

  5. Jan 2021 — Dec 2021 [monthly]

    Completed

Show 16 earlier versions
  1. Sep 2020 — Jan 2021 [monthly]

    Completed

  2. Aug 2020 — Sep 2020 [monthly]

    Completed

  3. Jul 2020 — Aug 2020 [monthly]

    Completed

  4. May 2020 — Jul 2020 [monthly]

    Completed

  5. Mar 2020 — May 2020 [monthly]

    Completed

  6. Dec 2019 — Mar 2020 [monthly]

    Completed

  7. Nov 2019 — Dec 2019 [monthly]

    Completed

  8. Oct 2019 — Nov 2019 [monthly]

    Completed

  9. Jan 2019 — Oct 2019 [monthly]

    Completed

  10. Dec 2018 — Jan 2019 [monthly]

    Completed

  11. Sep 2018 — Dec 2018 [monthly]

    Completed

  12. Jun 2018 — Sep 2018 [monthly]

    Completed

  13. May 2018 — Jun 2018 [monthly]

    Completed

  14. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NANone

  15. Dec 2017 — Apr 2018 [monthly]

    Completed NA

    Status: RecruitingCompleted

  16. Jan 2017 — Dec 2017 [monthly]

    Recruiting NA

    First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .